Atilla Turgay

Summary

Country: Canada

Publications

  1. ncbi Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ
    Michael G Aman
    The Nisonger Center, Ohio State University, 1581 Dodd Drive, Columbus, OH 43210-1257, USA
    J Child Adolesc Psychopharmacol 14:243-54. 2004
  2. ncbi Aggression and disruptive behavior disorders in children and adolescents
    Atilla Turgay
    The Scarborough Hospital, 3050 Lawrence Avenue East, Scarborough, Ontario, M1P 2V5, Canada
    Expert Rev Neurother 4:623-32. 2004
  3. ncbi Psychopharmacological treatment of oppositional defiant disorder
    Atilla Turgay
    Toronto ADHD Clinic, University of Toronto, Toronto, Ontario, Canada
    CNS Drugs 23:1-17. 2009
  4. ncbi Lifespan persistence of ADHD: the life transition model and its application
    Atilla Turgay
    Toronto ADHD Clinic, University of Toronto, Toronto, Ontario, Canada
    J Clin Psychiatry 73:192-201. 2012
  5. ncbi Treatment of comorbidity in conduct disorder with attention-deficit hyperactivity disorder (ADHD)
    Atilla Turgay
    Department of Psychiatry, The Scarborough Hospital, Toronto, Canada
    Essent Psychopharmacol 6:277-90. 2005
  6. ncbi Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs
    Atilla Turgay
    Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
    Pediatrics 110:e34. 2002
  7. ncbi Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs
    Richard Snyder
    Royal University Hospital, Saskatoon, Saskatchewan, Canada
    J Am Acad Child Adolesc Psychiatry 41:1026-36. 2002
  8. ncbi Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders
    Sarah Shea
    IWK Health Centre, and Dalhousie University, Halifax, Nova Scotia, Canada
    Pediatrics 114:e634-41. 2004

Collaborators

Detail Information

Publications8

  1. ncbi Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ
    Michael G Aman
    The Nisonger Center, Ohio State University, 1581 Dodd Drive, Columbus, OH 43210-1257, USA
    J Child Adolesc Psychopharmacol 14:243-54. 2004
    ..CONCLUSION: Risperidone was a safe and effective treatment, with or without a combined psychostimulant, for both disruptive behavior disorders and comorbid ADHD in children...
  2. ncbi Aggression and disruptive behavior disorders in children and adolescents
    Atilla Turgay
    The Scarborough Hospital, 3050 Lawrence Avenue East, Scarborough, Ontario, M1P 2V5, Canada
    Expert Rev Neurother 4:623-32. 2004
    ..Drugs such as risperidone (Risperdal, Janssen-Cilag) have documented effectiveness and safety in children and adolescents, and can be used in treatment...
  3. ncbi Psychopharmacological treatment of oppositional defiant disorder
    Atilla Turgay
    Toronto ADHD Clinic, University of Toronto, Toronto, Ontario, Canada
    CNS Drugs 23:1-17. 2009
    ..Mood regulators, alpha(2)-agonists and antidepressants may also have a role as second-line agents in the treatment of ODD and its co-morbidities...
  4. ncbi Lifespan persistence of ADHD: the life transition model and its application
    Atilla Turgay
    Toronto ADHD Clinic, University of Toronto, Toronto, Ontario, Canada
    J Clin Psychiatry 73:192-201. 2012
    ..Such an approach must recognize and address known patient- and systems-based challenges of long-term mental health treatment, shifting of clinical presentations of ADHD, and commonality of psychiatric comorbidity with ADHD...
  5. ncbi Treatment of comorbidity in conduct disorder with attention-deficit hyperactivity disorder (ADHD)
    Atilla Turgay
    Department of Psychiatry, The Scarborough Hospital, Toronto, Canada
    Essent Psychopharmacol 6:277-90. 2005
    ....
  6. ncbi Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs
    Atilla Turgay
    Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
    Pediatrics 110:e34. 2002
    ..Disruptive behavior disorders were defined as oppositional defiant disorder, disruptive behavior disorder, and conduct disorder as per the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria...
  7. ncbi Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs
    Richard Snyder
    Royal University Hospital, Saskatoon, Saskatchewan, Canada
    J Am Acad Child Adolesc Psychiatry 41:1026-36. 2002
    ..245). CONCLUSIONS: Risperidone appears to be an adequately tolerated and effective treatment in children with subaverage IQs and severe disruptive behaviors such as aggression and destructive behavior...
  8. ncbi Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders
    Sarah Shea
    IWK Health Centre, and Dalhousie University, Halifax, Nova Scotia, Canada
    Pediatrics 114:e634-41. 2004
    ..To investigate the efficacy and safety of risperidone for the treatment of disruptive behavioral symptoms in children with autism and other pervasive developmental disorders (PDD)...